Initial Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Initial Therapeutics's estimated annual revenue is currently $2.2M per year.
- Initial Therapeutics's estimated revenue per employee is $94,348
Employee Data
- Initial Therapeutics has 23 Employees.
- Initial Therapeutics grew their employee count by 0% last year.
Initial Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, Platform Biology | Reveal Email/Phone |
2 | Research Study Coordinator | Reveal Email/Phone |
Initial Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Initial Therapeutics?
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$2.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 23 | -8% | $33.9M |
#2 | $4M | 23 | 44% | N/A |
#3 | $14.1M | 23 | -34% | N/A |
#4 | $4.8M | 23 | 10% | N/A |
#5 | $1.6M | 23 | N/A | N/A |